Clinical trial
Development of the PRIME Test for the Identification of Prostate Cancer Patients' Biomarkers Through Non-invasive Liquid Biopsies
NCT06981377 is registered in ClinicalTrials.gov with Santa Chiara Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of the PRIME Test for the Identification of Prostate Cancer Patients' Biomarkers Through Non-invasive Liquid Biopsies
- Lead sponsor
- Santa Chiara Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 7, 2019
- Completion date
- January 31, 2027
- Enrollment
- 800 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic prostate cancer